Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention
Clinical trial NCT02456740 · COMPLETED
Trial details
- NCT number
- NCT02456740
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-17
- Primary completion
- 2016-09-05
- Enrollment
- 955
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.